We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BMRA market cap is 6.55M. The company's latest EPS is USD -0.3554 and P/E is -1.10.
Quarter End | Aug 2023 | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 1.71M | 1.57M | 1.02M | 1.12M | 1.81M |
Operating Income | -1.23M | -1.61M | -2.06M | -1.53M | -1.37M |
Net Income | -1.13M | -1.51M | -1.92M | -1.42M | -1.32M |
Year End May 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 6.69M | 7.2M | 18.87M | 5.34M | 5.42M |
Operating Income | -2.4M | -6.52M | -4.53M | -7.22M | -6.37M |
Net Income | -2.34M | -6.47M | -4.53M | -7.14M | -5.98M |
Quarter End | Aug 2023 | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 13.22M | 11.83M | 10.34M | 9.25M | 7.87M |
Total Liabilities | 2.45M | 2.45M | 2.53M | 2.66M | 2.52M |
Total Equity | 10.77M | 9.38M | 7.81M | 6.59M | 5.35M |
Year End May 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 17.26M | 11.82M | 11.37M | 14.45M | 9.25M |
Total Liabilities | 3.05M | 2.59M | 3.05M | 2.73M | 2.66M |
Total Equity | 14.21M | 9.23M | 8.33M | 11.72M | 6.59M |
Quarter End | Aug 2023 | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -1.67M | -2.52M | -4.32M | -5.36M | -1.34M |
Investing | -63k | -75k | -91k | -115k | N/A |
Financing | N/A | N/A | N/A | -81k | N/A |
Year End May 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -4.3M | -5.25M | -481k | -5.44M | -5.36M |
Investing | -119k | -295k | -170k | -78k | -115k |
Financing | 12.37M | 1.11M | 2.4M | 9.39M | -81k |
Market Cap | 6.55M |
Price to Earnings Ratio | -1.10 |
Price to Sales Ratio | 1.21 |
Price to Cash Ratio | 1.57 |
Price to Book Ratio | 1 |
Dividend Yield | - |
Shares Outstanding | 16.82M |
Average Volume (1 week) | 2.18M |
Average Volume (1 Month) | 665.5k |
52 Week Change | -56.72% |
52 Week High | 2.13 |
52 Week Low | 0.2415 |
Spread (Intraday) | 0.01 (3.37%) |
Company Name | Biomerica Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.biomerica.com |
Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions